242 related articles for article (PubMed ID: 19820225)
1. Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
Khanna D; Distler O; Avouac J; Behrens F; Clements PJ; Denton C; Foeldvari I; Giannini E; Huscher D; Kowal-Bielecka O; Lovell D; Matucci-Cerinic M; Mayes M; Merkel PA; Nash P; Opitz CF; Pittrow D; Rubin L; Seibold JR; Steen V; Strand CV; Tugwell PS; Varga J; Zink A; Furst DE; ;
J Rheumatol; 2009 Oct; 36(10):2356-61. PubMed ID: 19820225
[TBL] [Abstract][Full Text] [Related]
2. Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.
Distler O; Behrens F; Pittrow D; Huscher D; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Furst DE;
Arthritis Rheum; 2008 Jun; 59(6):867-75. PubMed ID: 18512721
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis - continuing progress in developing clinical measures of response.
Furst D; Khanna D; Matucci-Cerinic M; Clements P; Steen V; Pope J; Merkel P; Foeldvari I; Seibold J; Pittrow D; Polisson R; Strand V
J Rheumatol; 2007 May; 34(5):1194-200. PubMed ID: 17477486
[TBL] [Abstract][Full Text] [Related]
5. Measuring outcomes in PAH: the gap between the measures that are used and their validity.
Furst DE
Ann N Y Acad Sci; 2007 Jun; 1107():410-6. PubMed ID: 17804569
[TBL] [Abstract][Full Text] [Related]
6. Development of a provisional core set of response measures for clinical trials of systemic sclerosis.
Khanna D; Lovell DJ; Giannini E; Clements PJ; Merkel PA; Seibold JR; Matucci-Cerinic M; Denton CP; Mayes MD; Steen VD; Varga J; Furst DE;
Ann Rheum Dis; 2008 May; 67(5):703-9. PubMed ID: 17893248
[TBL] [Abstract][Full Text] [Related]
7. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.
Merkel PA; Clements PJ; Reveille JD; Suarez-Almazor ME; Valentini G; Furst DE;
J Rheumatol; 2003 Jul; 30(7):1630-47. PubMed ID: 12858472
[TBL] [Abstract][Full Text] [Related]
8. Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group.
Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
J Rheumatol; 2010 Jan; 37(1):105-15. PubMed ID: 19955042
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension.
Chow S; Pope JE; Mehta S
Clin Exp Rheumatol; 2008; 26(6):1012-7. PubMed ID: 19210864
[TBL] [Abstract][Full Text] [Related]
10. Scope and Consistency of Outcomes Reported in Trials of Patients With Systemic Sclerosis.
Sumpton D; Bigot A; Sautenet B; Craig JC; Hassett G; Thakkar V; Tugwell P; Tong A
Arthritis Care Res (Hoboken); 2020 Oct; 72(10):1449-1458. PubMed ID: 31309737
[TBL] [Abstract][Full Text] [Related]
11. Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis.
Huscher D; Pittrow D; Distler O; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Kowal-Bielecka O; Avouac J; Behrens F; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE;
Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S47-52. PubMed ID: 20576214
[TBL] [Abstract][Full Text] [Related]
12. Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O; Fransen J; Avouac J; Becker M; Kulak A; Allanore Y; Distler O; Clements P; Cutolo M; Czirjak L; Damjanov N; Del Galdo F; Denton CP; Distler JHW; Foeldvari I; Figelstone K; Frerix M; Furst DE; Guiducci S; Hunzelmann N; Khanna D; Matucci-Cerinic M; Herrick AL; van den Hoogen F; van Laar JM; Riemekasten G; Silver R; Smith V; Sulli A; Tarner I; Tyndall A; Welling J; Wigley F; Valentini G; Walker UA; Zulian F; Müller-Ladner U;
Ann Rheum Dis; 2017 Aug; 76(8):1327-1339. PubMed ID: 27941129
[TBL] [Abstract][Full Text] [Related]
13. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
14. Disease activity indices in systemic sclerosis: a systematic literature review.
Melsens K; De Keyser F; Decuman S; Piette Y; Vandecasteele E; Smith V
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):186-192. PubMed ID: 27385265
[TBL] [Abstract][Full Text] [Related]
15. Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features.
Hoffmann-Vold AM; Distler O; Murray B; Kowal-Bielecka O; Khanna D; Allanore Y;
RMD Open; 2019; 5(1):e000826. PubMed ID: 30997150
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed.
Denton CP; Avouac J; Behrens F; Furst DE; Foeldvari I; Humbert M; Huscher D; Kowal-Bielecka O; Matucci-Cerinic M; Nash P; Opitz CF; Pittrow D; Rubin LJ; Seibold JR; Distler O
Arthritis Res Ther; 2011 Jun; 13(3):114. PubMed ID: 21699746
[TBL] [Abstract][Full Text] [Related]
17. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.
Thakkar V; Nikpour M; Stevens WM; Proudman SM
Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials.
Humbert M; Singh M; Furst DE; Khanna D; Seibold JR
Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v33-v37. PubMed ID: 28992168
[TBL] [Abstract][Full Text] [Related]
19. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.
Avouac J; Huscher D; Furst DE; Opitz CF; Distler O; Allanore Y;
Ann Rheum Dis; 2014 Jan; 73(1):191-7. PubMed ID: 23349131
[TBL] [Abstract][Full Text] [Related]
20. Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020.
Maltez N; Hughes M; Brown E; Hickey V; Park H; Shea B; Herrick AL; Pauling JD; Proudman S; Merkel PA
Semin Arthritis Rheum; 2021 Jun; 51(3):640-643. PubMed ID: 33947582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
